Oppositely, HOXA1 expression was markedly reduced in breast cancer (BRCA), colon adenocarcinoma (COAD), kidney chromophobe (KICH), and kidney renal clear cell carcinoma (KIRC) than normal tissues. This evidence concerns the gene HOXA1 and invasive breast carcinoma.